Position in OGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$175,884
+$72,677 QoQ
Shares Held
12,990
-24.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#244
of 626 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meeder Advisory Services, Inc. holds $77,619,936 across 13 Drug Manufacturers - General names. OGN ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,367 | $24,428,792 | |
| 2 | JNJ |
Johnson & Johnson
|
62,731 | $15,931,792 | |
| 3 | ABBV |
AbbVie Inc.
|
51,588 | $12,981,604 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,788 | $8,068,258 | |
| 5 | AMGN |
Amgen Inc
|
15,199 | $5,503,861 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
34,965 | $4,417,478 | |
| 7 | PFE |
Pfizer Inc
|
110,339 | $2,656,963 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,270 | $1,686,537 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,884 | 12,990 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $103,207 | 17,230 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $341,578 | 47,640 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $725,385 | 67,920 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $345,721 | 35,715 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $378,697 | 25,433 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $288,120 | 19,311 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $197,823 | 10,341 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $224,884 | 10,864 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||